Form 4 for BSX Boston Scientific
Accepted 2021-11-16 00:00:00 ET · period of report 2021-11-15 · accession 0001225208-21-013899 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-11-16 | 2021-11-15 | BSX | WICHMANN DAVID S | Dir | P - Purchase | $41.98 | +25.0K | 25.0K | New | +$1.05M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-15 | P | A | 25,000 | $41.98 | 25,000 | D | — | — | (F1) Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $41.79 to, $42.09, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. |